Tamoxifen binding sites heterogeneity in breast cancer: a comparative study with steroid hormone receptors.
Steroid receptors and tamoxifen binding sites (TBS) were assayed in the soluble fraction of 121 primary breast cancers. Scatchard analysis of TBS in high speed supernatant (100,000 g) showed one population of binding sites; however, biphasic plots were obtained in low speed supernatants (40,000 g). Isoelectric focussing of supernatants preincubated with radioactive tamoxifen identified two classes of TBS (pI 4.1-4.6) which have different binding affinities and bind neither oestradiol nor diethylstilbestrol. Association between TBS and steroid receptors was: TBS positive/progesterone receptor positive 32.6%, TBS positive/glucocorticoid receptor positive 52.7%, TBS positive/oestrogen receptor positive 60% and TBS positive/androgen receptor positive 72.2%. We conclude that heterogeneous TBS are present in low speed fractions and can be easily separated from the oestrogen receptor by isoelectric focussing. The association between TBS and steroid receptor status could be of clinical value in the management of primary breast cancer.
Leo
G
G
Department of Biochemistry, Faculty of Basic Medical Sciences, Queen Mary & Westfield College, London, U.K.
Cappiello
G
G
Poltronieri
P
P
Giardina
C
C
Manca
C
C
Storelli
C
C
Marsigliante
S
S
D001943:Breast Neoplasms / Q000737:chemistry*; D005260:Female; D006801:Humans; D007525:Isoelectric Focusing; D011944:Receptors, Androgen / Q000032:analysis; D011956:Receptors, Cell Surface / Q000032:analysis*; D011955:Receptors, Drug; D011960:Receptors, Estrogen / Q000032:analysis*; D011965:Receptors, Glucocorticoid / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
D011944:Receptors, Androgen; D011956:Receptors, Cell Surface; D011955:Receptors, Drug; D011960:Receptors, Estrogen; D011965:Receptors, Glucocorticoid; D011980:Receptors, Progesterone